Abstract
The published data on the regulation of telomerase activity are systemized. The structure and functions of telomeres and telomerase are described. The main pathways of epigenetic regulation of telomerase activity—modification of the TERT (telomerase reserve transcriptase) gene histone and its methylation— are described. Particular attention is paid to the regulation of telomerase activity at the transcriptional level (transcriptional activators and inhibitors of TERT, as well as two-way transcription regulators) and posttranscriptional regulation (alternative splicing of TERT mRNA, phosphorylation, and ubiquitination of TERT).
Similar content being viewed by others
References
Akutagawa, O., Nishi, H., Kyo, S., et al., Early growth response-1 mediates up-regulation of telomerase in placenta, Placenta, 2007, vol. 28, nos. 8–9, pp. 920–927.
Akutagawa, O., Nishi, H., Kyo, S., et al., Early growth response-1 mediates downregulation of telomerase in cervical cancer, Cancer Sci., 2008, vol. 99, no. 7, pp. 1401–1406.
Aravindan, N., Veeraraghavan, J., Madhusoodhanan, R., et al., Curcumin regulates low-linear energy transfer ?-radiation-induced NF?B-dependent telomerase activity in human neuroblastoma cells, Int. J. Radiat. Oncol., Biol., Phys., 2011, vol. 79, no. 4, pp. 1206–1215.
Autexier, C. and Lue, N.F., The structure and function of telomerase reverse transcriptase, Ann. Rev. Biochem., 2006, vol. 75, pp. 493–517.
Baskaran, R., Wood, L.D., Whitaker, L.L., et al., Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation, Nature, 1997, vol. 387, pp. 516–519.
Bogdanov, A.A., Telomeres and telomerase, Soros. Obraz. Zh., 1998, vol. 12, pp. 12–18.
Boggess, J.F., Zhou, C., Bae-Jump, V.L., et al., Estrogen receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines, Gynecol. Oncol., 2006, vol. 103, no. 2, pp. 417–424.
Bryce, L.A., Morrison, N., Hoare, S.F., et al., Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization, Neoplasia, 2000, vol. 2, pp. 197–201.
Bu, X., Jia, F., Wang, W., et al., Coupled down-regulation of mTOR and telomerase activity during fluorouracilinduced apoptosis of hepatocarcinoma cells, BMC Cancer, 2007, vol. 7, pp. 208–216.
Cary, K.L., James, R.M., and Collins, K., RNA binding domain of telomerase reverse transcriptase, Mol. Cell. Biol., 2001, vol. 21, no. 4, pp. 990–1000.
Chang, J.T., Lu, Y.C., Chen, Y.J., et al., hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head-neck cancer cells, Br. J. Cancer, 2006, vol. 94, no. 6, pp. 870–878.
Chen, J.L., Blasco, M.A., and Greider, C.W., Secondary structure of vertebrate telomerase RNA, Cell, 2000, vol. 100, no. 5, pp. 503–514.
Chen, Y.J., Campbell, H.G., Wiles, A.K., et al., PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma, Cancer Res., 2008, vol. 68, no. 14, pp. 5724–5732.
Cherlet, T. and Murphy, L.C., Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors, Mol. Cell. Biochem., 2007, vol. 306, nos. 1–2, pp. 33–42.
Choi, J.H., Min, N.Y., Park, J., et al., TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116, Biochem. Biophys. Res. Commun., 2010, vol. 391, no. 1, pp. 449–454.
Colgin, M.L., Wilkinson, C., Englezou, A., et al., The hTERTa splice variant is a dominant negative inhibitor of telomerase activity, Neoplasia, 2000, vol. 2, no. 5, pp. 426–432.
Collins, K., Physiological assembly and activity of human telomerase complexes, Mech. Ageing Dev., 2008, vol. 129, nos. 1–2, pp. 91–98.
Daniel, M., Peek, G.W., and Tollefsbol, T.O., Regulation of the human catalytic subunit of telomerase, Gene, 2012, vol. 2, no. 498, pp. 135–146.
de Jesus, B.B. and Blasco, M.A., Telomerase at the intersection of cancer and aging, Trends Genet., 2013, vol. 29, no. 9, pp. 513–520.
de Lange, T., Shelterin: the protein complex that shapes and safeguards human telomeres, Gen. Dev., 2005, vol. 19, pp. 2100–2110.
de Lange, T., How telomeres solve the end-protection problem, Science, 2009, vol. 326, no. 5955, pp. 948–952.
Dessain, S.K., Yu, H., and Reddel, R.R., Methylation of the human telomerase gene CpG island, Cancer Res., 2000, vol. 60, no. 3, pp. 537–541.
Endoh, T., Tsuji, N., Asanuma, K., et al., Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription, Exp. Cell Res., 2005, vol. 305, no. 2, pp. 300–311.
Forsythe, H.L., Jarvis, J.L., Turner, J.W., et al., Stable association of hsp90 and p23, but not hsp70, with active human telomerase, J. Biol. Chem., 2001, vol. 276, no. 19, pp. 15571–15574.
Frank, A.K., Tran, D.C., Qu, R.W., et al., The shelterin TIN2 subunit mediates recruitment of telomerase to telomeres, PLoS Genet., 2015, vol. 11, no. 7, pp. 1–19.
Galitskii, V.A., The epigenetic theory of aging, Tsitologiya, 2009, vol. 51, no. 5, pp. 388–397.
Gewin, L., Myers, H., Kiyono, T., and Galloway, D.A., Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex, Gen. Dev., 2004, vol. 18, no. 18, pp. 2269–2282.
Greider, C.W. and Blackburn, E.H., Identification of a specific telomere terminal transferase activity in Tetrahymena extracts, Cell, 1985, vol. 43, pp. 405–413.
Griffith, J.D., Comeau, L., Rosenfield, S., et al., Mammalian telomeres end in a large duplex loop, Cell, 1999, vol. 97, pp. 503–514.
Günes, C., Lichtsteiner, S., Vasserot, A.P., and Englert, C., Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1, Cancer Res., 2000, vol. 60, no. 8, pp. 2116–2121.
Guo, C., Armbruster, B.N., Price, D.T., and Counter, C.M., In vivo regulation of hTERT expression and telomerase activity by androgen, J. Urol., 2003, vol. 170, no. 2, pp. 615–618.
Haendeler, J., Hoffmann, J., Rahman, S., et al., Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation, FEBS Lett., 2003, vol. 536, nos. 1–3, pp. 180–186.
Hayflick, L. and Moorhead, P.S., The serial cultivation of human diploid cell strains, Experim. Cell Res., 1961, no. 25, pp. 585–621.
Hershko, A., Ciechanover, A., and Varshavsky, A., The ubiquitin system, Nat. Med., 2000, vol. 6, no. 10, pp. 1073–1081.
Hisatomi, H., Ohyashiki, K., Ohyashiki, J.H., et al., Expression profile of a ?-deletion variant of the human telomerase reverse transcriptase gene, Neoplasia, 2003, vol. 5, no. 3, pp. 193–197.
Hiyama, K., Hirai, Y., Kyoizumi, S., et al., Activation of telomerase in human lymphocytes and hematopoietic progenitor cells, J. Immunol., 1995, vol. 155, pp. 3711–3715.
Holt, S.E., Aisner, D.L., Baur, J., et al., Functional requirement of p23 and Hsp90 in telomerase complexes, Gen. Dev., 1999, vol. 13, no. 7, pp. 817–826.
Kang, S.S., Kwon, T., Kwon, D.Y., and Do, S.I., Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit, J. Biol. Chem., 1999, vol. 274, pp. 13085–13090.
Kelleher, C., Kurth, I., and Lingner, J., Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro, Mol. Cell. Biol., 2005, vol. 25, pp. 808–818.
Kharbanda, S., Kumar, V., Dhar, S., et al., Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase, Curr. Biol., 2000, vol. 10, no. 10, pp. 568–575.
Korolenkova, L.I., Human papillomavirus associated with infection as the markers of the emergence and development of cervical intraepithelial neoplasia: from scientific development to clinical practice, Opukholi Zhenskoi Reprod. Sist., 2010, no. 4, pp. 64–70.
Kusumoto, M., Ogawa, T., Mizumoto, K., et al., Adenovirus- mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells, Clin. Cancer Res., 1999, vol. 5, no. 8, pp. 2140–2147.
Kyo, S., Takakura, M., Kanaya, T., et al., Estrogen activates telomerase, Cancer Res., 1999, vol. 59, no. 23, pp. 5917–5921.
Kyo, S., Takakura, M., Taira, T., et al., Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT), Nucleic Acids Res., 2000, vol. 28, no. 3, pp. 669–677.
Kyo, S., Takakura, M., Fujiwara, T., and Inoue, M., Understanding and exploiting hTERT promoter regula tion for diagnosis and treatment of human cancers, Cancer Sci., 2008, vol. 99, no. 8, pp. 1528–1538.
Lee, J.H., Khadka, P., Baek, S.H., and Chung, I.K., CHIP promotes human telomerase reverse transcriptase degradation and negatively regulates telomerase activity, J. Biol. Chem., 2010, vol. 285, no. 53, pp. 42033–42045.
Lei, M., Zaug, A.J., Podell, E.R., and Cech, T.R., Switching human telomerase on and off with hPOT1 protein in vitro, J. Biol. Chem., 2005, vol. 280, pp. 20449–20456.
Lewis, K.A. and Tollefsbol, T.O., Regulation of the telomerase reverse transcriptase subunit through epigenetic mechanisms, Front. Genet., 2016, vol. 7, no. 83, pp. 1–12.
Li, H., Zhao, L., Yang, Z., et al., Telomerase is controlled by protein kinase C alpha in human breast cancer cells, J. Biol. Chem., 1998, vol. 27, no. 50, pp. 33436–33442.
Li, N.F., Kocher, H.M., Salako, M.A., et al., A novel function of colony-stimulating factor 1 receptor in hTERT immortalization of human epithelial cells, Oncogene, 2009, vol. 28, no. 5, pp. 773–780.
Lingner, J., Cooper, J.P., and Cech, T.R., Telomerase and DNA end replication: no longer a lagging strand problem? Science, 1995, vol. 269, pp. 1533–1534.
Lingner, J., Hughes, T.R., Shevchenko, A., et al., Reverse transcriptase motifs in the catalytic subunit of telomerase, Science, 1997, vol. 276, pp. 561–567.
Listerman, I., Sun, J., Gazzaniga, F.S., et al., The major reversetranscriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis, Cancer Res., 2013, vol. 73, no. 9, pp. 2817–2828.
Liu, D., O’Connor, M.S., Qin, J., and Songyang, Z., Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins, J. Biol. Chem., 2004, vol. 279, pp. 51338–51342.
Liu, L., Ishihara, K., Ichimura, T., et al., MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity, J. Biol. Chem., 2009, vol. 284, no. 8, pp. 5165–5174.
Lue, N.F., Adding to the ends: what makes telomerase processive and how important is it? BioEssays, 2004, vol. 26, no. 9, pp. 955–962.
Maida, M., Kyo, S., and Kanaya, T., Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway, Oncogene, 2002, vol. 21, no. 26, pp. 4071–4079.
Martínez, P., Gómez-López, G., David, G., et al., A genetic interaction between RAP1 and telomerase reveals an unanticipated role for RAP1 in telomere maintenance, Aging Cell, 2016, pp. 1–13.
Mason, M., Schuller, A., and Skordalakes, E., Telomerase structure function, Curr. Opin. Struct. Biol., 2011, vol. 21, pp. 92–100.
Misri, S., Pandita, S., Kumar, R., and Pandita, T.K., Telomeres, histone code, and DNA damage response, Cyt. Gen. Res., 2009, vol. 122, nos. 3–4, pp. 297–307.
Mitchell, J.R. and Collins, K., Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase, Mol. Cell, 2000, vol. 6, no. 2, pp. 361–371.
Montanaro, L., Calienni, M., Ceccarelli, C., et al., Relationship between dyskerin expression and telomerase activity in human breast cancer, Cell. Oncol., 2008, vol. 30, no. 6, pp. 483–490.
Nakamura, T.M., Morin, G.B., Chapman, K.B., et al., Telomerase catalytic subunit homologs from fission yeast and human, Science, 1997, vol. 277, no. 5328, pp. 955–959.
Nandakumar, J., Bell, C.F., Weidenfeld, I., et al., The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity, Nature, 2012, vol. 492, pp. 285–289.
O’Connor, M.S., Safari, A., Xin, H., et al., A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly, Proc. Natl. Acad. Sci. U.S.A., 2006, vol. 103, no. 32, pp. 11874–11879.
Olovnikov, A.M., The redusome hypothesis of aging and the control of biological time during individual development, Biochemistry (Moscow), 2003, vol. 68, no. 1, pp. 2–33.
Pendina, A.A., Grinkevich, V.V., Kuznetsova, T.V., and Baranov, V.S., DNA methylation as one of the main mechanisms of gene activity regulation, Ekol. Genet., 2004, vol. 2, no. 1, pp. 27–37.
Renaud, S., Loukinov, D., and Bosman, F.T., CTCF binds the proximal exonic region of hTERT and inhibits its transcription, Nucleic Acids Res., 2005, vol. 33, no. 21, pp. 6850–6860.
Renaud, S., Loukinov, D., Abdullaev, Z., et al., Dual role of DNA methylation inside and outside of CTCFbinding regions in the transcriptional regulation of the telomerase hTERT gene, Nucleic Acids Res., 2007, vol. 35, no. 4, pp. 1245–1256.
Ruggero, D., Grisendi, S., Piazza, F., et al., Dyskeratosis congenital and cancer in mice deficient in ribosomal RNA modification, Science, 2003, vol. 299, no. 5604, pp. 259–562.
Sæbøe-Larssen, S., Fossberg, E., and Gaudernack, G., Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumor tissues, BMC Mol. Biol., 2006, vol. 7, pp. 26–36.
Schmidt, J.C. and Cech, T.R., Human telomerase: biogenesis, trafficking, recruitment, and activation, Gen. Dev., 2015, vol. 29, no. 11, pp. 1095–1105.
Shafman, T., Khanna, K.K., Kedar, P., et al., Interaction between ATM protein and c-Abl in response to DNA damage, Nature, 1997, vol. 38, pp. 520–523.
Shats, I., Milyavsky, M., Tang, X., et al., p53-Dependent down regulation of telomerase is mediated by p21waf1, J. Biol. Chem., 2004, vol. 279, no. 49, pp. 50976–50985.
Shaulian, E. and Karin, M., AP-1 as a regulator of cell life and death, Nat. Cell Biol., 2002, vol. 4, pp. 131–136.
Sheng, W.Y., Chen, Y.R., and Wang, T.C., A major role of PKC theta and NF?B in the regulation of hTERT in human T lymphocytes, FEBS Lett., 2006, vol. 580, no. 30, pp. 6819–6824.
Sitaram, R.T., Degerman, S., Ljungberg, B., et al., Wilms’ tumor 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways, Br. J. Cancer, 2010, vol. 103, no. 8, pp. 1255–1262.
Sommer, A., Hilfenhaus, S., Menkel, A., et al., Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity, Curr. Biol., 1997, vol. 7, no. 6, pp. 357–365.
Stansel, R.M., de Lange, T., and Griffith, J.D., T-loop assembly in vitro involves binding of TRF2 near the 3 telomeric overhang, EMBO J., 2001, vol. 20, pp. 5532–5540.
Swanson, M.J., Baribault, M.E., Israel, J.N., and Bae, N.S., Telomere protein RAP1 levels are affected by cellular aging and oxidative stress, Biomed. Rep., 2016, vol. 5, no. 2, pp. 181–187.
Takakura, M., Kyo, S., Kanaya, T., et al., Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells, Cancer Res., 1999, vol. 59, no. 3, pp. 551–557.
Takakura, M., Kyo, S., Inoue, M., et al., Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells, Mol. Cell. Biol., 2005, vol. 25, no. 18, pp. 8037–8043.
Tazi, J. and Bird, A., Alternative chromatin structure of CpG islands, Cell, 1990, vol. 60, pp. 909–920.
Tejera, A.M., Stagno d’Alcontres, M., Thanasoula, M., et al., TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice, Dev. Cell, 2011, vol. 18, no. 5, pp. 775–789.
Ulaner, G.A., Hu, J.F., Vu, T.H., et al., Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts, Cancer Res., 1998, vol. 58, no. 18, pp. 4168–4172.
van Steensel, B. and de Lange, T., Control of telomere length by the human telomeric protein TRF1, Nature, 1997, vol. 385, no. 6618, pp. 740–743.
Wang, Z., Kyo, S., Takakura, M., et al., Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway, Cancer Res., 2000, vol. 60, pp. 5376–5381.
Wei, C. and Price, M., Protecting the terminus: t-loops and telomere end binding proteins, Cell. Mol. Life Sci., 2003, vol. 60, pp. 2283–2294.
Wojtyla, A., Gladych, M., and Rubis, B., Human telomerase activity regulation, Mol. Biol. Rep., 2011, vol. 38, pp. 3339–3349.
Wooten-Blanks, L.G., Song, P., Senkal, C.E., and Ogretmen, B., Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1, FASEB J., 2007, vol. 21, no. 12, pp. 3386–3397.
Wu, K.J., Grandori, C., Amacker, M., et al., Direct activation of TERT transcription by c-Myc, Nat. Genet., 1999, vol. 21, no. 2, pp. 220–224.
Wyatt, H.D., West, S.C., and Beattie, T.L., InTERTpreting telomerase structure and function, Nucleic Acids Res., 2010, vol. 38, no. 17, pp. 5609–5622.
Xu, D., Wang, Q., Gruber, A., et al., Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells, Oncogene, 2000, vol. 19, no. 45, pp. 5123–5133.
Xu, D., Dwyer, J., Li, H., et al., Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc, J. Biol. Chem., 2008, vol. 283, no. 35, pp. 23567–23580.
Yang, X.J. and Seto, E., Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression, Curr. Opin. Genet. Dev., 2003, vol. 13, no. 2, pp. 143–153.
Ye, J.Z., Donigian, J.R., van Overbeek, M., et al., TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres, J. Biol. Chem., 2004, vol. 279, no. 45, pp. 47264–47271.
Yi, X., White, D.M., Aisner, D.L., et al., An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity, Neoplasia, 2000, vol. 2, no. 5, pp. 433–440.
Yuan, Z.M., Huang, Y., Whang, Y., et al., Role for the c-Abl tyrosine kinase in the growth arrest response to DNA damage, Nature, 1996, vol. 382, pp. 272–274.
Zhang, Q., Kim, N.K., and Feigon, J., Architecture of human telomerase RNA, Proc. Nat. Acad. Sci. U.S.A., 2011, vol. 108, no. 51, pp. 20325–20332.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.S. Nalobin, A.A. Galiakberova, S.I. Alipkina, A.I. Glukhov, 2017, published in Uspekhi Sovremennoi Biologii, 2017, Vol. 137, No. 5, pp. 435–449.
Rights and permissions
About this article
Cite this article
Nalobin, D.S., Galiakberova, A.A., Alipkina, S.I. et al. Regulation of Telomerase Activity. Biol Bull Rev 8, 142–154 (2018). https://doi.org/10.1134/S2079086418020068
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079086418020068